
zzso and its associated zzso disorders are growing health concerns in the US and zzso In the US alone, more than two-thirds of the adult population is classified as either overweight or obese zzso highlighting the need to develop new, effective treatments for these zzso Whereas the hormone zzso is well known for its peripheral effects on zzso contraction during zzso and milk ejection during zzso release of zzso from zzso and zzso terminals within the central nervous system zzso is implicated in both the formation of zzso behaviors and in the control of energy zzso Recent findings demonstrate that chronic administration of zzso reduces food intake and body weight in zzso obese zzso and genetically obese zzso with impaired or defective zzso zzso zzso chronic systemic administration of zzso out to zzso zzso the effects of central administration on body weight loss in zzso zzso at doses that do not result in the development of zzso Furthermore, these effects are coupled with induction of zzso (a marker of zzso zzso in zzso areas zzso zzso zzso complex zzso linked to the control of meal size and zzso areas zzso zzso zzso linked to the regulation of food intake and body zzso This review zzso the potential central and peripheral targets by which zzso may inhibit body weight gain, its regulation by zzso and zzso signals, and its potential use as a therapy that can circumvent zzso resistance and reverse the behavioral and zzso abnormalities associated with zzso and genetically obese zzso 

